Improving access to novel treatments for treatment-resistant depression: The potential role of specialist clinics in Australia
Australian & New Zealand Journal of Psychiatry May 26, 2026 Yash Giri, Paul Furst, Colleen Loo et al. 1 citation
Treatment-resistant depression is a condition with significant morbidity, despite the current standard of treatment, including traditional pharmacotherapy, psychotherapy, augmentation strategies and electroconvulsive therapy. While novel therapies have emerged, such as ketamine/esketamine, transcranial magnetic stimulation and psilocybin-assisted therapy, the uptake of these treatments is...